SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-176597
Filing Date
2022-06-17
Accepted
2022-06-17 16:51:55
Documents
15
Period of Report
2022-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340163d8k.htm   iXBRL 8-K 29452
2 EX-1.1 d340163dex11.htm EX-1.1 203767
3 EX-5.1 d340163dex51.htm EX-5.1 10561
7 GRAPHIC g340163g0617091456913.jpg GRAPHIC 2782
  Complete submission text file 0001193125-22-176597.txt   434348

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nexi-20220617.xsd EX-101.SCH 2834
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20220617_lab.xml EX-101.LAB 17980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20220617_pre.xml EX-101.PRE 11244
9 EXTRACTED XBRL INSTANCE DOCUMENT d340163d8k_htm.xml XML 3340
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 221024662
SIC: 2834 Pharmaceutical Preparations